¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"choroid plexus carcinoma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • comedo carcinoma
    ¸éÆ÷¾ÏÁ¾, ¿©µå¸§Áý¸ð¾ç¾ÏÁ¾
  • carcinoma
    ¾ÏÁ¾
  • carcinoma in situ
    Á¦ÀÚ¸®¾ÏÁ¾
  • corpus carcinoma
    ÀڱøöÅë¾ÏÁ¾, ÀÚ±ÃüºÎ¾ÏÁ¾
  • duct carcinoma
    °ü¾ÏÁ¾
  • duct cell carcinoma
    °ü¼¼Æ÷¾ÏÁ¾
  • eccrine carcinoma
    ¿¡Å©¸°¾ÏÁ¾
  • embryonal carcinoma
    ¹è¾Æ¾ÏÁ¾
  • epidermoid carcinoma
    Ç¥ÇǸð¾ç¾ÏÁ¾
  • follicular carcinoma
    °©»ó»ù¼ÒÆ÷¾ÏÁ¾, ¼ÒÆ÷¾ÏÁ¾
  • giant cell carcinoma
    °Å´ë¼¼Æ÷¾ÏÁ¾
  • glandular carcinoma
    »ù¾ÏÁ¾, ¼±¾ÏÁ¾
  • granulosa cell carcinoma
    °ú¸³¼¼Æ÷¾ÏÁ¾
  • hepatocellular carcinoma
    °£¼¼Æ÷¾ÏÁ¾
  • invasive carcinoma
    ħ½À¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • duct cell carcinoma
    °ü¼¼Æ÷¾ÏÁ¾
  • eccrine carcinoma
    ¿¡Å©¸°¶¡»ù¾ÏÁ¾
  • embryonal carcinoma
    ¹è¾Æ¾ÏÁ¾
  • epidermoid carcinoma
    (¢¡squamous cell) ÆíÆò¼¼Æ÷¾ÏÁ¾
  • follicular carcinoma
    °©»ó»ù¼ÒÆ÷¾ÏÁ¾, ¼ÒÆ÷¾ÏÁ¾
  • giant cell carcinoma
    °Å´ë¼¼Æ÷¾ÏÁ¾
  • glandular carcinoma
    (¢¡adenocarcinoma) »ù¾ÏÁ¾
  • granulosa cell carcinoma
    °ú¸³¼¼Æ÷¾ÏÁ¾
  • hepatocellular carcinoma
    °£¼¼Æ÷¾ÏÁ¾
  • inflammatory carcinoma
    ¿°Áõ¾ÏÁ¾
  • intraepithelial carcinoma
    »óÇdz»¾ÏÁ¾, Ç¥ÇǼӾÏÁ¾
  • invasive carcinoma
    ħ½À¾ÏÁ¾
  • islet cell carcinoma
    ¼¶¼¼Æ÷¾ÏÁ¾
  • large cell carcinoma
    Å«¼¼Æ÷¾ÏÁ¾, ´ë¼¼Æ÷¾ÏÁ¾
  • medullary carcinoma
    ¼ÓÁú¾ÏÁ¾, ¼öÁú¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • plexus
    ¾ó±â, ÃÑ(õ¿).
  • plexus anesthesia
    (½Å°æ)ÃѸ¶Ãë(¹ý)(ãêÌèõ¿Ø«ö­Ûö).
  • plexus aorticus abdominalis ³ª
    »À´ëµ¿¸Æ½Å°æ¾ó±â, º¹´ëµ¿¸Æ½Å°æÃÑ(ÜÙÓÞÔÑØæ ãêÌèõ¿).
  • plexus aorticus thoracicus ³ª
    °¡½¿´ëµ¿¸Æ½Å°æ¾ó±â, Èä´ëµ¿¸Æ½Å°æÃÑ(ýØÓÞÔÑ ØæãêÌèõ¿).
  • plexus arteriae cerebri anterioris ³ª
    ¾Õ´ë³úµ¿¸Æ¾ó±â, Àü´ë³úµ¿¸ÆÃÑ(îñÓÞ ÒàÔÑØæõ¿).
  • plexus arteriae cerebri mediae ³ª
    Áß°£´ë³úµ¿¸Æ¾ó±â, Áß´ë³úµ¿¸ÆÃÑ(ñéÓÞÒà ÔÑØæõ¿).
  • plexus arteriae chorioideae ³ª
    ¸Æ¶ô¸·µ¿¸Æ¾ó±â, ¸Æ¶ô¸·µ¿¸ÆÃÑ(ØæÕ©Ø¯ÔÑØæõ¿ ).
  • plexus auricularis posterior ³ª
    µÚ±Ó¹ÙÄû¾ó±â, ÈÄÀ̰³ÃÑ(ý­ì¼Ë¿õ¿).
  • plexus auricularis posterior ³ª
    µÚõ¤aÄû¾ó±â, ÈÄÀ̰³ÃÑ(ý­ì¼Ë¿õ¿).
  • plexus autonomici ³ª
    ÀÚÀ²½Å°æ¾ó±â, ÀÚÀ²½Å°æÃÑ(í»ëÏãêÌèõ¿).
  • plexus basilaris ³ª
    ³ú¹Ù´ÚÁ¤¸Æ¾ó±â, ³úÀúÁ¤¸ÆÃÑ(Òàî¼ð¡Øæõ¿).
  • plexus block
    ½Å°æÃÑÂ÷´Ü.
  • plexus brachialis ³ª
    ÆÈ½Å°æ¾ó±â, ¿Ï½Å°æÃÑ(èÓãêÌèõ¿).
  • plexus cardiacus profundus ³ª
    ±íÀº½ÉÀå½Å°æ¾ó±â, ½É½ÉÀå½Å°æÃÑ(ä¢ãýíôãêÌè õ¿).
  • plexus cardiacus superficialis ³ª
    ¾èÀº½ÉÀå½Å°æ¾ó±â, õ½ÉÀå½Å°æÃÑ(ô¼ãýíô ãêÌèõ¿).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • breast,carcinoma scirrhous
    °æÁú¼º (Ìãòõàõ)
  • brochioloalveolar carcinoma
    ¼¼±â°üÁö ÆóÆ÷¾ÏÁ¾(á¬Ñ¨Î·ò¨øËøàäßðþ)
  • bronchiolar carcinoma
    ¼¼±â°üÁö¼º ¾Ï(Á¾)(¡­àõäßðþ).
  • bronchogenic carcinoma
    ±â°üÁö¿ø¼º ¾ÏÁ¾(¡­äßðþ).
  • bronchogenic carcinoma
    ±â°üÁö¿ø¼º ¾ÏÁ¾(¡­äßðþ)
  • carcinoma
    ¾ÏÁ¾
  • carcinoma
    ¾ÏÁ¾ (äßðþ)
  • carcinoma dose
    Á¦¾Ï·®.
  • carcinoma en cuirasse
    °©¿Ê ¾Ï(Á¾)
  • carcinoma erysipelatodes
    ´Üµ¶¾ç¾ÏÁ¾
  • carcinoma in situ
    »óÇdz»¾ÏÁ¾(ß¾ù«Ò®äßðþ), µ¿¼Ò³»¾ÏÁ¾(ÔÒá¶Ò®äßðþ), ÀνÃÅõ¾ÏÁ¾
  • carcinoma of prostate
    Àü¸³¼±¾Ï
  • carcinoma of thyroid, papillary
    °©»ó¼± À¯µÎ»ó¾ÏÁ¾
  • carcinoma pearl
    ¾ÏÁ¾ÁÖ(¾ÏÁ¾ÁÖ).
  • carcinoma portionis<³ª>
    ÀÚ±ÃÁúºÎ¾ÏÁ¾(í­ÏàòóÝ»äßðþ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Cardiac plexus
    ½ÉÀå½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ½ÉÀå½Å°æÃÑ
  • Inferior rectal plexus
    ¾Æ·¡°ðâÀڽŰæ¾ó±â
    [¿¾ ¿ë¾î] ÇÏÁ÷À嵿¸Æ½Å°æÃÑ
  • Inferior dental plexus
    ¾Æ·¡Ä¡¾Æ½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ÇÏÄ¡½Å°æÃÑ
  • Anterior external vertebral venous plexus
    ¾Õ¹Ù±ùôÁÖÁ¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] Àü¿ÜÃß°ñÁ¤¸ÆÃÑ
  • Anterior internal vertebral venous plexus
    ¾Õ¼ÓôÁÖÁ¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] Àü³»Ãß°ñÁ¤¸ÆÃÑ
  • Superficial subpapillary venous plexus
    ¾èÀºÀ¯µÎ¹ØÁ¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] õÀ¯µÎÇÏÁ¤¸ÆÃÑ
  • Ganglion plexus
    ¾ó±â½Å°æÀý
    [¿¾ ¿ë¾î] ½Å°æÀýÃÑ
  • Iliac plexus
    ¾ûµ¢½Å°æ¾ó±â
    [¿¾ ¿ë¾î] Àå°ñµ¿¸Æ½Å°æÃÑ
  • Sacral plexus
    ¾ûÄ¡½Å°æ¾ó±â
    [¿¾ ¿ë¾î] õ°ñ½Å°æÃÑ
  • Sacral venous plexus
    ¾ûÄ¡Á¤¸Æ¾ó±â
    [¿¾ ¿ë¾î] õ°ñÁ¤¸ÆÃÑ
  • Common carotid plexus
    ¿Â¸ñ½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ÃѰ浿¸Æ½Å°æÃÑ
  • Superior rectal plexus
    À§°ðâÀڽŰæ¾ó±â
    [¿¾ ¿ë¾î] »óÁ÷Àå½Å°æÃÑ
  • Gastric plexus
    À§½Å°æ¾ó±â
    [¿¾ ¿ë¾î] À§½Å°æÃÑ
  • Superior hypogastric plexus [Presacral nerve]
    À§¾Æ·§¹è½Å°æ¾ó±â [¾ûÄ¡¾Õ½Å°æ¾ó±â]
    [¿¾ ¿ë¾î] »óÇϺ¹½Å°æÃÑ
  • Superior dental plexus
    À§Ä¡¾Æ½Å°æ¾ó±â
    [¿¾ ¿ë¾î] »óÄ¡½Å°æÃÑ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
ca about [Lat. circa]; candle; carcinoma
CCL carcinoma cell line; certified cell line; Charcot-Leyden crystal; continuing care level; critical ca...
CIN 3, CIN III cervical intraepithelial neoplasia, grade 3 (severe dysplasia and carcinoma in situ)
CIS carcinoma in situ; catheter-induced spasm; central inhibitory state; Chemical Information Service; c...
CRC cardiovascular reflex conditioning; clinical research center; colorectal carcinoma; concentrated red...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
Ca Carcinoma
CIS Carcinoma in Situ
MCA Carcinoma-associated Antigen
CC Cervical carcinoma
CCC Cholangiocellular carcinoma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • arsenical basal cell carcinoma
    ºñ¼Ò¼º ±âÀú¼¼Æ÷ ¾Ï
  • basal cell carcinoma
    ±âÀú ¼¼Æ÷ ¾Ï, ±âÀú ¼¼Æ÷ ¾ÏÁ¾
    1. »óÇÇÀÇ ±âÀú ¼¼Æ÷¸¦ ´àÀº ±âº» ±¸Á¶¸¦ °¡Áö´Â »óÇÇ ¼¼Æ÷ ½Å»ý¹°. À̰ÍÀº »óÇÇ ¼¼Æ÷ÀÇ ±âÀú ¼¼Æ÷, ¸ð³¶À̳ª ÇÇÁö¼±ÀÇ ¿Ü¹æ ¼¼Æ÷, ƯÈ÷ ¾È¸éÀÇ °¡¿îµ¥ 1/3¿¡¼­ ¹ß»ýÇÑ´Ù. µå¹°°Ô ÀüÀ̵ÇÁö¸¸ ±¹¼ÒÀûÀ¸·Î ħ¹üÇÑ´Ù. ±¸°­ Á¡¸·¿¡¼­´Â ¹ß»ýÇÏÁö ¾Ê´Â´Ù. Çѱ¹ÀÎ ÇǺΠ¾Ç¼º Á¾¾ç Áß °¡Àå ¸¹Àº ÇüÀÌ´Ù. ÀüÀ̰¡ Àß ¾ÈµÇ¸ç Àç¹ßÀ²ÀÌ ÀûÀº Áß°£ ¾Ç¼ºµµÀÌ´Ù. ±¸°­ÀÇ ±âÀú ¼¼Æ÷ ¸ð¹Ý ÁõÈıº°ú °ü·ÃÀÌ ÀÖ´Ù. 2. Ç¥ÇÇ ±âÀúÃþÀÇ ¾Ç¼º Á¾¾ç.
  • basaloid squamous carcinoma
    ±âÀú »óÇÇ ¼¼Æ÷ ¾ÏÁ¾
    Çô, ÀεÎ, Èĵο¡ ¹ß»ýÇÏ¸ç ³ôÀº ¾Ç¼ºµµ¸¦ º¸ÀδÙ.
  • basosquamous carcinoma
    ±âÀú ÆíÆò ¼¼Æ÷ ¾ÏÁ¾
    Á¶Á÷ÇÐÀûÀ¸·Î ±âÀú ¼¼Æ÷¿Í ÆíÆò ¼¼Æ÷ÀÇ ¿ä¼Ò¸¦ ¸ðµÎ °¡Áö°í ÀÖ´Â ¾ÏÁ¾. ±¸°­³»¿¡¼­ Á¾Á¾ °üÂûµÇ¸ç ±âÀú ¼¼Æ÷ ¾ÏÁ¾º¸´Ù ÀüÀ̰¡ ´õ Àß µÇ´Â °ÍÀ¸·Î »ý°¢µÇ°í ÀÖ´Ù.
  • bladder carcinoma
    ¹æ±¤ ¾ÏÁ¾
  • brochioloalveolar carcinoma
    ¼¼±â°üÁö ÆóÆ÷ ¾ÏÁ¾
  • bronchiolar carcinoma
    ¼¼±â°üÁö¼º ¾Ï, ¼¼±â°üÁö¼º ¾ÏÁ¾
  • bronchogenic carcinoma
    ±â°üÁö ¾Ï
    ±â°üÁö¿¡ »ý±ä ¾Ï. Á¶Á÷ÇÐÀûÀ¸·Î´Â ¼± ¾Ï, ÆíÆò»óÇÇ ¾Ï, ¹ÌºÐÈ­ ¾Ï µîÀ¸·Î ºÐ·ùÇÑ´Ù. »ê¾÷ÀÇ ¹ß´Þ¿¡ ¼ö¹ÝµÈ ´ë±â ¿À¿° ¹× Èí¿¬ µîÀ¸·Î ÀÎÇØ ±Ù·¡¿¡ ÀÌ ÀÓÁ¾ÀÇ ¹ß»ý ºóµµ°¡ ±Þ°ÝÈ÷ »ó½ÂÇϰí ÀÖ´Ù.
  • carcinoma adenomatosum
    ¼± ¾ÏÁ¾
    ¼± Á¶Á÷¿¡¼­ »ý±â´Â ¾Ï. ¶Ç´Â ¼± Á¶Á÷À¸·Î ÀÎ½ÄµÉ ¼ö ÀÖ´Â ±¸Á¶ÀÇ ¼¼Æ÷·Î Çü¼ºµÇ´Â ¾Ï. ¼±¾ÏÀº ÁÖ¿äÇÑ ¼¼Æ÷ ¹è¿­ÀÇ Çü¿¡ ÀÇÇÏ¿© À¯µÎ»ó, Æ÷»ó µîÀ¸·Î ºÐ·ùµÈ´Ù. ¶Ç´Â ¼¼Æ÷ÀÇ Æ¯¼öÇÑ »ý¼º¹°¿¡ ÀÇÇÏ¿© Á¡¾×¼º ¼±¾Ï µîÀ¸·Î ºÐ·ùµÈ´Ù.
  • carcinoma erysipelatodes
    ´Üµ¶¾ç ¾ÏÁ¾
  • carcinoma in situ
    »óÇdz» ¾ÏÁ¾, µ¿¼Ò³» ¾ÏÁ¾, ÀνÃÅõ ¾ÏÁ¾
    ÇÇºÎ¿Í Á¡¸·À» ÀÌȯÇÏ´Â Çü¼º Àå¾Ö¼º »óÇÇ ÁúȯÀ¸·Î¼­ Àü¾Ï º´¼Ò·Î »ý°¢µÇ°í ÀÖ´Ù. °¢È­ ÀÌ»óÁõÀÌ ½ÉÇÏÁö¸¸ ħ¹üÀº µÇÁö ¾ÊÀº »óÅÂÀÌ´Ù.
  • carcinoma of thyroid
    °©»ó¼± ¾Ï
    º´¸®Á¶Á÷ÇÐÀûÀ¸·Î À¯µÎ¼± ¾Ï, ¿©Æ÷¼± ¾Ï, ¼ö¾ç ¾Ï, ¹ÌºÐÈ­ ¾Ï ¹× °©»ó¼± ¿ø¹ßÀÇ ¾Ç¼º ¸²ÇÁÁ¾À¸·Î ³ª´µ¾î Áø´Ù. °©»ó¼± ¾ÏÀº º´¸®Á¶Á÷ÀÇ Çü¿¡µû¶ó¼­ ³ªÅ¸³ª´Â ¸ð¾ç, Ä¡·á ¹æÄ§, ¿¹Èİ¡ µÎµå·¯Áö°Ô ´Ù¸£´Ù. ºÐÈ­ ¾ÏÀº °©»ó¼±°ú ¼Ò¼Ó ¸²ÇÁÀýÀÇ ¹üÀ§°¡ ±¹ÇѵǾî ÀÖ´Â °ÍÀÌ ´ëºÎºÐÀε¥ Æó³ª »ÀÀÇ ÀüÀ̸¦ °¡Á®¿À´Â °Íµµ ÀÖ´Ù. ¹ÌºÐÈ­¾ÏÀº ¹æ»ç¼± Á¶»ç¿Í Ç×¾ÏÁ¦¸¦ »ç¿ëÇÏ°í ¾Ç¼º ¸²ÇÁÁ¾¿¡´Â ¹æ»ç¼± Á¶»ç°¡ È¿°úÀûÀÌ´Ù.
  • carcinoma ossificans
    È­°ñ¼º ¾ÏÁ¾
    °£Áú¿¡ À¯°ñ, °ñ È­»ýÀÌ ÀϾ´Â ¾ÏÁ¾.
  • carcinoma portionis
    Àڱà ÁúºÎ ¾ÏÁ¾
  • carcinoma telangiectaticum
    ¸ð¼¼Ç÷°ü È®À强 ¾Ï, ¸ð¼¼Ç÷°ü È®À强 ¾ÏÁ¾
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
carcinoma, hepatocellular Primary carcinoma of the liver cells. It ranges from a well-differentiated tumour difficult to distinguish from normal hepatocytes to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic or may form giant cells. Several classification schemes have been suggested. Hepatocellular carcinoma is very rare in the united states and western europe, but it is one of the most common cancers in eastern asia and sub-saharan africa. The cases are preponderantly male and, racially, whites have the lowest rates.
(12 Dec 1998)
carcinoma, infiltrating duct An invasive (infiltrating) carcinoma of the breast. This carcinoma in which no special histological feature is recognised is designated nos or not otherwise specified and is by far the most common ductal tumour, accounting for almost 70% of breast cancers. It is characterised by stony hardness upon palpation. It commonly metastasizes to the axillary lymph nodes and its prognosis is the poorest of the various ductal types.
(12 Dec 1998)
carcinoma in situ Cancer that involves only the cells in which it began and has not spread to other tissues. Lobular carcinoma in situ is found in the lobules of the breast. Ductal carcinoma in situ (also called intraductal carcinoma) arises in the ducts.
(16 Dec 1997)
carcinoma, intraductal, noninfiltrating A noninvasive (noninfiltrating) carcinoma of the breast characterised by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma. Its true incidence is uncertain but all noninvasive breast carcinomas comprise almost 5% of all neoplastic lesions of the female breast, with this carcinoma accounting for about 50% of these, or 2.5%-2.8% of all tumours.
(12 Dec 1998)
carcinoma, islet cell A carcinoma of the islets of langerhans.
(12 Dec 1998)
carcinoma, large cell A tumour of undifferentiated (anaplastic) cells of large size. It is usually bronchogenic.
(12 Dec 1998)
carcinoma, lewis lung A carcinoma discovered by dr. Margaret r. Lewis of the wistar institute in 1951. This tumour originated spontaneously as a carcinoma of the lung of a c57bl mouse. The tumour does not appear to be grossly haemorrhagic and the majority of the tumour tissue is a semifirm homogeneous mass. It is also called 3ll and llc and is used as a transplantable malignancy.
(12 Dec 1998)
carcinoma, lobular A infiltrating (invasive) breast cancer, relatively uncommon, accounting for only 5%-10% of breast tumours in most series. It is often an area of ill-defined thickening in the breast, in contrast to the dominant lump characteristic of ductal carcinoma. It is typically composed of small cells in a linear arrangement with a tendency to grow around ducts and lobules. There is likelihood of axillary nodal involvement with metastasis to meningeal and serosal surfaces.
(12 Dec 1998)
carcinoma, medullary A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies.
(12 Dec 1998)
carcinoma, merkel cell A carcinoma arising from merkel cells located in the basal layer of the epidermis and occurring most commonly as a primary neuroendocrine carcinoma of the skin. Merkel cells are tactile cells of neuroectodermal origin and histologically show neurosecretory granules. The skin of the head and neck are a common site of merkel cell carcinoma, occurring generally in elderly patients.
(12 Dec 1998)
carcinoma, mucoepidermoid A tumour of both low- and high-grade malignancy. The low-grade grow slowly, appear in any age group, and are readily cured by excision. The high-grade behave aggressively, widely infiltrate the salivary gland and produce lymph node and distant metastases. Mucoepidermoid carcinomas account for about 21% of the malignant tumours of the parotid gland and 10% of the sublingual gland. They are the most common malignant tumour of the parotid.
(12 Dec 1998)
carcinoma myxomatodes An obsolete term for a form of colloid cancer in which there is myxomatous metaplasia of the cellular fibrous stroma.
(05 Mar 2000)
carcinoma, neuroendocrine A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round "blue cells", granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumours include carcinoids, small ("oat") cell carcinomas, medullary carcinoma of the thyroid, merkel cell tumour, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumours, and pheochromocytoma. Neurosecretory granules are found within the tumour cells.
(12 Dec 1998)
carcinoma, non-small-cell lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. They are dealt with collectively because of the shared properties of poor response to conventional chemotherapy and the potential for cure with surgical resection in a fraction of patients.
(12 Dec 1998)
carcinoma, papillary A malignant neoplasm characterised by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á